Notice Number: NOT-OD-13-027
Release Date: January 24, 2013
The PHS 2013-2 Omnibus Solicitation of the NIH, CDC, FDA, and ACF for SBIR/STTR Grant Applications and SF 424 (R&R) Application Guide for SBIR/STTR Grant Applications are now available. The solicitation consists of: (1) parent funding opportunity announcement (FOA) for SBIR, (2) a parent FOA for STTR, and (3) narrative descriptions of the programs and research topics (in PDF - 1 MB and MS Word - 1 MB formats). The due dates for CY 2013 are April 5, August 5, and December 5, 2013. AIDS and AIDS-related applications are due May 7, September 7, 2013, and January 7, 2014.
HHS is committed to implementing all the provisions of the SBIR/STTR Reauthorization Act of 2011 (P.L. 112-81). NIH has set up a new website to keep the small business research community abreast of its implementation plan for the many changes resulting from the reauthorization. The site will be updated as the implementation process moves forward. The Small Business Administration (SBA) released the revised, final size rule on December 27, 2012, with a 30-day implementation window effective January 28, 2013. The new Omnibus FOAs (and all HHS- and NIH-issued FOAs) must also be published to allow sufficient time for the small business community to prepare applications for the first application due date of April 5, 2013. Given this and, furthermore, due to the complexities of implementing certain provisions, the issuance of the PHS 2013-2 Omnibus FOAs implements some, but not all, of the provisions of the SBIR/STTR Reauthorization Act.
HHS intends to revise, amend or re-issue the Omnibus FOAs in the middle of 2013 to implement additional reauthorization provisions as guidance from the SBA is received and electronic system and form updates at NIH and SBA are implemented.
Provisions implemented with current Omnibus issuances include:
New award budget language implementing new award guidelines, maximum award size and a waiver process to exceed (see the FOAs for details).
Allow applicants to sub-contract with a federal laboratory without the need for an SBA waiver (required previously).
Allow applicants to request up to $5,000 to obtain their own Technical Assistance vendor if they wish. In doing so, applicants cannot qualify for the NIH-provided Technical Assistance Programs.
HHS will implement the provisions below as guidance from the SBA is received and electronic system and form updates at NIH and SBA are realized; however at this time, the Omnibus FOAs DO NOT currently allow the following:
NIH is currently updating its electronic systems and forms to allow applicants to switch programs at Phase II. Only NIH participates in the STTR program; CDC, FDA, and ACF do not.
Per the reauthorization, this provision will only be available to NIH SBIR applicants once implemented. NIH is currently updating its electronic systems and forms to allow applicants to apply for a Direct Phase II SBIR award. Additionally, this provision will be piloted by NIH by issuing targeted FOAs and will not be available on the Omnibus FOAs. When issued, Direct to Phase II FOAs may be found here.
While SBA issued its final size rule pertaining to SBIR/STTR company eligibility (including VCOCs, etc. for the SBIR program) on December 27, 2012, the implementation date is January 28, 2013. Implementing the 'VCOC provision' first required SBA issuing the final rule and now entails updating the NIH electronic systems, forms, and application instructions. Additionally, all SBIR/STTR applicants will be required to register at the SBA registration database (in late stage development) prior to applying to an agency for an SBIR or STTR award. It was not feasible to include all of the requirements in our current Omnibus FOAs given the above and the requirement to issue the FOAs with sufficient time prior to the first application due date of April 5, 2013.
HHS has, therefore, decided that it is in the best interest of the small business community to issue new Omnibus FOAs with some reauthorization provisions implemented rather than removing the April 5 due date and inadvertenly risk delaying funding of meritorious projects . HHS intends to revise, amend or re-issue the Omnibus FOAs in the middle of 2013 to implement additional reauthorization provisions as guidance from SBA is received and electronic system and form updates at NIH and SBA are implemented. This ultimately allows HHS to retain the April 5, 2013 application due date and award cycle.
Applicants are required to follow the guidance and instructions in the Omnibus FOAs as issued.